The authors regret that, during production of the article, Fig. 2 and Supplementary Figure S3 were inadvertently interchanged. The image published as Fig. 2 in the main text corresponds to Supplementary Figure S3, and the image published as Supplementary Figure S3 in the supplementary material corresponds to Fig. 2. All other elements of the article, including the figure legends, in-text citations, and results reported in the main text, are correct and unaffected by this error.
Fig. 2.
Molecular landscape of CUPs. Oncoprint of genomic alterations detected in 165 patients with molecular analyses results. CNS, Central Nervous System; CUP, Cancer of Unknown Primary; TMB, Tumour Mutational Burden; MSI, Microsatellite Instability; MSS, Microsatellite Stable; HRD, Homologous Repair Deficiency; WGS, Whole-Genome Sequencing; WTS, Whole-Transcriptome Sequencing.
Supplementary Figure 3.
Oncoprint of actionable genomic alterations detected in 163 patients with DNA analyses results, according to OncoKB Therapeutic Level of Evidence 1, 2, 3A, 3B.
The correct Fig. 2 and Supplementary Figure S3 and their legends are provided below:
The authors would like to apologise for any inconvenience caused.